BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 2, 2004
View Archived Issues
Preclinical evidence suggests a role for Flt3-ligand in the treatment of diabetes
Read More
Antiarrhythmic effects of ranolazine in canine left ventricle preparations
Read More
Benefits of atorvastatin in the prevention of recurrent cardiovascular events after ACS
Read More
The Medicines Company updates second quarter developments
Read More
Key development projects at Roche made significant progress in first half of 2004
Read More
Novel series of MC4 receptor agonists highlighted at recent ACS meeting
Read More
Preliminary data on the efficacy of a tenofovir/emtricitabine combination in HIV-infected patients
Read More
Long-term efficacy of efavirenz-containing antiretroviral regimens in HIV infection
Read More
Cannabinoids found to improve urge incontinence in MS patients
Read More
Good safety profile reported for darifenacin in OAB
Read More
Takeda develops new metastin derivatives for preventing cancer metastasis
Read More
New mitotic kinesin KSP inhibitors discovered by Merck researchers
Read More
Neurocrine presents new melanocortin MC3/MC4 modulators and their use
Read More
Novel MIF ligands and their use covered by Takeda patent
Read More
Novel 17beta-HSD-3 inhibitors and their use claimed by Schering-Plough
Read More
New S1P1/Edg1 agonists developed by Merck scientists
Read More
MitoKor presents adenine nucleotide translocase ligands and their use
Read More
Long-term improvement of urinary incontinence achieved with solifenacin
Read More
Imvamune progresses during first half of 2004
Read More
MedImmune terminates rheumatoid arthritis and psoriasis trials for Vitaxin
Read More
Phase I/II trial for EW-A-401
Read More
IC-MedTech licenses Apatone
Read More
Vaccine programs progress at Sinovac
Read More
Scandinavian phase II trial of Alpharadin extended to U.K.
Read More
FDA approval for Parcopa
Read More
Yamanouchi submits YM-905 for approval in Japan
Read More
North American Scientific to end Theseus Imaging subsidiary operations
Read More
EP-013420 enters phase I study
Read More
Oralin submitted for approval in Ecuador
Read More
AVI to test AVI-4020 in West Nile virus neuroinvasive disease
Read More
